Breaking News, Collaborations & Alliances

Debiopharm & Oncodesign Partner on Cancer Imaging Tech

Collaboration aims to propel radiopharmaceuticals in preclinical research.

Author Image

By: Charlie Sternberg

Associate Editor

Debiopharm Research & Manufacturing S.A., a Swiss-based global biopharmaceutical company aiming to cure cancer and infectious diseases, and Oncodesign Services, a CRO specialized in drug discovery and preclinical services, have signed a license agreement for the use of Debiopharm’s AbYlink technology for preclinical services. AbYlink is a regio-selective bioconjugation technology ideally suited for preparing conjugates for use in therapeutic and non-invasive diagnostic applications. Oncod...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters